Publication: Opposite malaria and pregnancy effect on oral bioavailability of artesunate - A population pharmacokinetic evaluation
Issued Date
2015-10-01
Resource Type
ISSN
13652125
03065251
03065251
Other identifier(s)
2-s2.0-84942549519
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
British Journal of Clinical Pharmacology. Vol.80, No.4 (2015), 642-653
Suggested Citation
Frank Kloprogge, Rose McGready, Aung Pyae Phyo, Marcus J. Rijken, Warunee Hanpithakpon, Hla Hla Than, Nathar Hlaing, Naw Thida Zin, Nicholas P.J. Day, Nicholas J. White, François Nosten, Joel Tarning Opposite malaria and pregnancy effect on oral bioavailability of artesunate - A population pharmacokinetic evaluation. British Journal of Clinical Pharmacology. Vol.80, No.4 (2015), 642-653. doi:10.1111/bcp.12660 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/36307
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Opposite malaria and pregnancy effect on oral bioavailability of artesunate - A population pharmacokinetic evaluation
Other Contributor(s)
Abstract
© 2015 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society. Aim The aim was to compare the pharmacokinetic properties of artesunate and dihydroartemisinin in the same women: i) pregnant with acute uncomplicated malaria on day 1 and 2, ii) pregnant with convalescent malaria on day 7 and iii) in a healthy state 3 months post-partum on day 1, 2 and 7. Methods Non-linear mixed-effects modelling was used to compare plasma concentration-time profiles of artesunate and dihydroartemisinin over 7 days of treatment following oral and intravenous artesunate administration to pregnant women with uncomplicated Plasmodium falciparum malaria during their second or third trimesters of pregnancy. The same women were restudied 3 months after delivery when fully recovered. Non-compartmental results of the same study have been published previously. Results Twenty pregnant patients on the Thailand-Myanmar border were studied and 15 volunteered to be restudied 3 months post-partum. Malaria and pregnancy had no effect on the pharmacokinetic properties of artesunate or dihydroartemisinin after intravenous artesunate administration. However, malaria and pregnancy had opposite effects on the absorption of orally administered artesunate. Malaria increased the absolute oral bioavailability of artesunate by 87%, presumably by inhibiting first pass effect, whereas pregnancy decreased oral bioavailability by 23%. Conclusions The population pharmacokinetic analysis demonstrated opposite effects of malaria and pregnancy on the bioavailability of orally administered artesunate. Lower drug exposures during the second and third trimesters of pregnancy may contribute to lower cure rates and thus the development of drug resistance. Dose optimization studies are required for artesunate containing artemisinin-based combination therapies (ACTs) in later pregnancy.